Rivaroxaban
Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation, Treatment of deep vein thrombosis (DVT), Treatment of pulmonary embolism (PE), Reduction in risk of recurrence of DVT and/or PE, Prophylaxis of DVT following hip or knee replacement surgery, Prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients
Boxed warning
- WARNING: (A) PREMATURE DISCONTINUATION OF XARELTO INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA A. Premature discontinuation of XARELTO increases the risk of thrombotic events Premature discontinuation of any oral anticoagulant, including XARELTO, increases the risk of thrombotic events. If anticoagulation with XARELTO is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and ... (see full label)
High-alert medication
- Antithrombotic agents - DOACs (class)
Indications
- Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation
- Treatment of deep vein thrombosis (DVT)
- Treatment of pulmonary embolism (PE)
- Reduction in risk of recurrence of DVT and/or PE
- Prophylaxis of DVT following hip or knee replacement surgery
- Prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients
Adult dosing
- nonvalvular afib: dose: 20; unit: mg; route: PO; interval: once daily with evening meal; 15 mg if CrCl <=50; fixed: true; labelExcerpt: Nonvalvular Atrial Fibrillation : 15 or 20 mg, once daily with food
- dvt pe treatment: dose: 15; unit: mg; route: PO; interval: twice daily x21 days, then 20 mg once daily; fixed: true; labelExcerpt: Treatment of DVT and/or PE : 15 mg orally twice daily with food for the first 21 days followed by 20 mg orally once daily with food for the remaining treatment
- post op vte prophylaxis: dose: 10; unit: mg; route: PO; interval: once daily (hip/knee replacement); fixed: true; labelExcerpt: Prophylaxis of DVT Following Hip or Knee Replacement Surgery : 10 mg orally once daily with or without food
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- mild: No adjustment; moderate: 15 mg once daily (AFib); Avoid (VTE/Prophylaxis if <15 mL/min); severe: 15 mg once daily (AFib); Avoid (VTE/Prophylaxis if <15 mL/min); failure: Avoid use; hemodialysis: Avoid use; note: CrCl <15 mL/min generally avoid; dose adjustment for AFib if CrCl 15-50 mL/min. Label: "CrCl ≥15 mL/min 15 mg twice daily ▼ after 21 days, transition to ▼ 20 mg once daily Take with food, at the same time each day CrCl <15 mL/min Avoid Use"
Hepatic adjustment
- Avoid use in Child-Pugh B and C hepatic impairment.
Contraindications
- Active pathological bleeding
- Severe hypersensitivity to Xarelto
Clinical pearls
- Pediatric dosing is weight-banded by label table; not reproduced here - consult pharmacy/current label
- Do not crush or split tablets; can crush 15/20 mg tablets for administration with food.
- No specific reversal agent available; not dialyzable.
- Monitor for neurological impairment if patient received neuraxial anesthesia/puncture.
- Take 15 mg and 20 mg doses with food; 2.5 mg and 10 mg can be taken with or without food.
Source and review
- DailyMed label (rivaroxaban, Xarelto), Set ID 10db92f9-2300-4a80-836b-673e1ae91610, effective 2026-09-10. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties